Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Zealand Pharma A/S |
| Bavarian Nordic A/S |
| BioPorto A/S |
| Initiator Pharma A/S |
| Curasight A/S |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| ZEAL | BAVA | BIOPOR | INIT | CURAS | STRAP | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -21% | 12% | -198% | NA | NA | NA | ||
| Fiscal Year - 1 | -58% | 17% | -86% | NA | NA | NA | ||
| Fiscal Year - 2 | -111% | -5% | -131% | NA | NA | NA | ||
| Fiscal Year - 3 | -70% | -8% | -78% | NA | NA | NA | ||
| Fiscal Year - 4 | -54% | 8% | -98% | NA | NA | NA | ||
| Fiscal Year - 5 | -48% | -17% | -171% | NA | NA | NA | ||
| Average | -61% | 1% | -127% | NA | NA | NA | ||
| Median | -56% | 2% | -114% | NA | NA | NA | ||
| Benchmarks | Ticker | |||||||
| Zealand Pharma A/S | CPSE:ZEAL | |||||||
| Bavarian Nordic A/S | CPSE:BAVA | |||||||
| BioPorto A/S | CPSE:BIOPOR | |||||||
| Initiator Pharma A/S | OM:INIT | |||||||
| Curasight A/S | NGM:CURAS | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | ZEAL | BAVA | BIOPOR | INIT | CURAS | STRAP | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 56 | 6,231 | 34 | NA | NA | NA | ||
| Fiscal Year | 63 | 5,716 | 36 | NA | NA | NA | ||
| Fiscal Year - 1 | 343 | 7,062 | 31 | NA | NA | NA | ||
| Fiscal Year - 2 | 104 | 3,151 | 29 | NA | NA | NA | ||
| Fiscal Year - 3 | 109 | 1,898 | 24 | NA | NA | NA | ||
| Fiscal Year - 4 | 192 | 1,852 | 23 | NA | NA | NA | ||
| Fiscal Year - 5 | 41 | 662 | 27 | NA | NA | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (1,186) | 1,321 | (82) | (11) | (34) | (0) | ||
| Fiscal Year | (1,079) | 988 | (68) | (13) | (37) | (0) | ||
| Fiscal Year - 1 | (704) | 1,475 | (56) | (23) | (26) | (26) | ||
| Fiscal Year - 2 | (966) | (347) | (76) | (38) | (18) | (38) | ||
| Fiscal Year - 3 | (755) | (465) | (57) | (21) | (8) | (78) | ||
| Fiscal Year - 4 | (669) | 278 | (62) | (9) | (6) | (633) | ||
| Fiscal Year - 5 | (572) | (347) | (70) | (8) | (1) | (337) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 3,587 | 13,621 | 71 | 24 | 28 | 19 | ||
| Latest Fiscal Quarter | 9,122 | 13,553 | 75 | 13 | 18 | 24 | ||
| Fiscal Year | 9,506 | 14,406 | 96 | 16 | 24 | 24 | ||
| Fiscal Year - 1 | 1,980 | 14,353 | 90 | 30 | 39 | 19 | ||
| Fiscal Year - 2 | 1,540 | 12,391 | 109 | 48 | 60 | 57 | ||
| Fiscal Year - 3 | 2,068 | 12,089 | 81 | 54 | 103 | 173 | ||
| Fiscal Year - 4 | 1,762 | 8,759 | 140 | 16 | 63 | 822 | ||
| Fiscal Year - 5 | 1,600 | 7,047 | 43 | 11 | 23 | 181 | ||
| Fiscal Year - 6 | 1,230 | 3,061 | 66 | 17 | NA | 441 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 2,838 | 10,174 | 42 | 24 | 23 | 14 | ||
| Latest Fiscal Quarter | 8,308 | 11,556 | 41 | 12 | 3 | 19 | ||
| Fiscal Year | 8,617 | 11,409 | 68 | 15 | 8 | 19 | ||
| Fiscal Year - 1 | 1,593 | 10,340 | 60 | 11 | 31 | 14 | ||
| Fiscal Year - 2 | 816 | 7,150 | 70 | 34 | 58 | 41 | ||
| Fiscal Year - 3 | 928 | 7,375 | 46 | 35 | 99 | 9 | ||
| Fiscal Year - 4 | 1,229 | 4,894 | 101 | 14 | 59 | 621 | ||
| Fiscal Year - 5 | 1,243 | 1,865 | 25 | 10 | 18 | 53 | ||
| Fiscal Year - 6 | 1,116 | 2,181 | 56 | 17 | NA | 388 | ||